Literature DB >> 20133211

What is the best method for measuring renal function in adults and children with cystic fibrosis?

Natalie Soulsby1, Hugh Greville, Kingsley Coulthard, Chris Doecke.   

Abstract

AIMS: To measure the glomerular filtration rate (GFR) in adults and children with cystic fibrosis (CF) using a radio-isotope technique as the gold standard and to compare this to serum creatinine based equations, serum cystatin C levels and tobramycin clearance, and to determine which method correlates most closely with measured GFR in this population. Crown Copyright (c) 2010. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20133211     DOI: 10.1016/j.jcf.2009.12.002

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  8 in total

1.  Urinary kidney injury biomarkers and tobramycin clearance among children and young adults with cystic fibrosis: a population pharmacokinetic analysis.

Authors:  Kevin J Downes; Min Dong; Tsuyoshi Fukuda; John P Clancy; Christopher Haffner; Michael R Bennett; Alexander A Vinks; Stuart L Goldstein
Journal:  J Antimicrob Chemother       Date:  2016-09-01       Impact factor: 5.790

2.  Renal function in pediatric cystic fibrosis patients in the first decade of life.

Authors:  Chanel Prestidge; Mark A Chilvers; A George F Davidson; Eva Cho; Vanessa McMahon; Colin T White
Journal:  Pediatr Nephrol       Date:  2010-12-29       Impact factor: 3.714

3.  Optimizing Estimated Glomerular Filtration Rate to Support Adult to Pediatric Pharmacokinetic Bridging Studies in Patients with Cystic Fibrosis.

Authors:  Ryan L Crass; Manjunath P Pai
Journal:  Clin Pharmacokinet       Date:  2019-10       Impact factor: 6.447

4.  Risk factors for chronic kidney disease in adults with cystic fibrosis.

Authors:  Bradley S Quon; Nicole Mayer-Hamblett; Moira L Aitken; Alan R Smyth; Christopher H Goss
Journal:  Am J Respir Crit Care Med       Date:  2011-07-28       Impact factor: 21.405

5.  Urinary Biomarkers of Aminoglycoside-Induced Nephrotoxicity in Cystic Fibrosis: Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin.

Authors:  Stephen J McWilliam; Daniel J Antoine; Andrea L Jorgensen; Rosalind L Smyth; Munir Pirmohamed
Journal:  Sci Rep       Date:  2018-03-23       Impact factor: 4.379

6.  Evaluation of bone disease in patients with cystic fibrosis and end-stage lung disease.

Authors:  Cécile A Robinson; Markus Hofer; Christian Benden; Christoph Schmid
Journal:  J Bras Pneumol       Date:  2019-02-28       Impact factor: 2.624

7.  Estimation of GFR in Patients With Cystic Fibrosis: A Cross-Sectional Study.

Authors:  Andrea Wallace; April Price; Erin Fleischer; Michael Khoury; Guido Filler
Journal:  Can J Kidney Health Dis       Date:  2020-01-15

Review 8.  Altered intravenous drug disposition in people living with cystic fibrosis: A meta-analysis integrating top-down and bottom-up data.

Authors:  Pieter-Jan De Sutter; Maxime Van Haeverbeke; Eva Van Braeckel; Stephanie Van Biervliet; Jan Van Bocxlaer; An Vermeulen; Elke Gasthuys
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2022-06-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.